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INTRODUCTION
The closure of cutaneous wounds involves complex tissue
movements such as hemorrhage, inflammation, re-epitheliza-
tion, granulation tissue formation, and the late remodeling
phase of repair (1). These events involve coordination of dozens
of types of cells and matrix proteins, which are all important
to control stages of the repair process. Previous studies have
demonstrated that endogenous growth factors, such as fibrob-
last growth factors (FGF) (2), platelet derived growth factors
(PDGF) (3), transforming growth factor-β(TGF-β ) (1) and
vascular endothelial growth factors (VEGF) (4) are the impor-
tant regulatory polypeptides for coordinating the healing
process. They are released from macrophages, fibroblasts, and
keratinocytes at the site of injury and they participate in the
regulation of re-epithelization, granulation tissue formation,
collagen synthesis and neovascularization. 
Ozone (O3) has been widely recognized as one of the best
bactericidal, antiviral and antifungal agents (5, 6) and it has
been used empirically as a clinical therapeutic agent for chron-
ic wounds, such as trophic ulcers, ischemic ulcers and dia-
betic wounds (7-9). The beneficial effects of O3 on wound
healing might be assumed to be due to decreased bacterial
infection, ameliorated impaired dermal wound healing or
increased oxygen tension by O3 exposure in the wound area
(10, 11). 
It was reported that O3 exposure is associated with activa-
tion of transcription factor NF-κ B; this is important to reg-
ulate inflammatory responses and eventually the entire pro-
cess of wound healing (5, 12, 13). It was shown that huge
amounts of PDGF and TGF-β 1 were released from platelets
in the heparinized plasma of a limb ischemia patient after
ozonation (14, 15). It has been revealed that there were sub-
stantial increases of steady-state mRNA levels of TGF-β 1 in
the fibroblasts that were co-cultured with bronchoepithelial
cells after O3 exposure (16). A recent study has shown that
hydrogen peroxide (H2O2) potently induced the VEGF ex-
pression in human keratinocytes which can stimulate wound
healing (17). From these previous studies of O3, we hypothe-
sized that O3 might enhance acute cutaneous wound heal-
ing, and this could be associated with growth factors such
as FGF, PDGF, TGF-βand VEGF.
Nowadays, O3 is profitably and practically employed as
ozonated olive oil; this contains the O3 molecule stabilized as
an ozonide between the double bonds of a monounsaturated
fatty acid such as oleic acid, which is ideal for the topical use
of O3 to treat chronically infected cutaneous and mucosal areas
of the body (5). Ozonated materials referred to as ozonides are
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Therapeutic Effects of Topical Application of Ozone on Acute 
Cutaneous Wound Healing
This study was undertaken to evaluate the therapeutic effects of topical ozonated
olive oil on acute cutaneous wound healing in a guinea pig model and also to elu-
cidate its therapeutic mechanism. After creating full-thickness skin wounds on the
backs of guinea pigs by using a 6 mm punch biopsy, we examined the wound heal-
ing effect of topically applied ozonated olive oil (ozone group), as compared to the
pure olive oil (oil group) and non-treatment (control group). The ozone group of
guinea pig had a significantly smaller wound size and a residual wound area than
the oil group, on days 5 (P<0.05) and 7 (P<0.01 and P<0.05) after wound surgery,
respectively. Both hematoxylin-eosin staining and Masson-trichrome staining reveal-
ed an increased intensity of collagen fibers and a greater number of fibroblasts in
the ozone group than that in the oil group on day 7. Immunohistochemical staining
demonstrated upregulation of platelet derived growth factor (PDGF), transforming
growth factor-β (TGF-β ) and vascular endothelial growth factor (VEGF) expressions,
but not fibroblast growth factor expression in the ozone group on day 7, as com-
pared with the oil group. In conclusion, these results demonstrate that topical appli-
cation of ozonated olive oil can accelerate acute cutaneous wound repair in a guinea
pig in association with the increased expression of PDGF, TGF-β , and VEGF.
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formed by the reaction of olefins with ozone. Any olefin can
be treated with gaseous ozone to form an ozonide. The ozonide
compositions have the capacity to deliver nascent oxygen deep
within the lesion without causing primary skin irritation. 
Ozonated oil has been used topically for the treatment of
chronic wounds, but there have been few studies concerning
with the therapeutic effects of ozonated olive oil on acute cuta-
neous wound healing in animal models. The present study
was designed to evaluate the therapeutic effect of topical ozo-
nated olive oil on acute cutaneous wound healing in a guinea
pig model, and to elucidate its therapeutic mechanisms that
are associated with such growth factors as FGF, PDGF, TGF-
β , and VEGF. 
MATERIALS AND METHODS
Animals
Sixteen female guinea pigs (400-450 g), aged 8-9 weeks,
were placed in a room that was under a 12-hr light and 12-
hr dark cycle. The animals were placed individually in sepa-
rate cages with ad libitum access to food and water. The ani-
mal care, handling, and experimental procedures were car-
ried out in accordance with a protocol approved by the Ani-
mal Care and Use Committee of the Catholic University of
Korea.
Wound biopsy
After 7 days of acclimation, the guinea pigs were anesthe-
sized with ketamine and their backs were shaved and then
sterilized with normal saline. The skin was then pinched and
folded, and a sterile biopsy punch (6 mm in diameter, Stiefel
Co., Offenbach, Germany) was used to make a full-thickness
hole in the skin. Two wounds were created on both sides of
the back for a total 4 circular wounds per animal. 
Application of topical ozonated olive oil
Two drops (about 0.1 mL) of ozonated olive oil (OZOO
�,
Aurora, Inc., Miami, FL, U.S.A.) were applied everyday to
two sites of the four wounds (Ozone group). Olive oil (OLO)
as a pure base was applied to a third wound (Oil group). As
a control group, nothing was applied on the fourth wound.
The wounds were then dressed with Opsite
�(Smith&Nephew,
Hull, U.K.) to cover them without dryness. An elastic ban-
dage was wrapped around the area to prevent further injury.
Measurement of wound closure
After each guinea pig was wounded as described above,
the wounds were photographed at indicated times by using
a digital camera (Canon 350D, Canon Inc., Tokyo, Japan) that
was placed at a 20 cm distance to help eliminate error in mea-
suring the size of the wounds. The photographic images were
analyzed by Canvas X10.0 software (ACDSEE Inc., Miami,
FL, U.S.A.) and the area of wound closure was measured by
using the same program. The parameters of the wounds, such
as wound size and the residual wound area, were measured
daily from the photographic images taken. 
* Measured parameters 
1) Wound size (mm2)
2) Residual wound area (%):
Area measured at the experiment day 
×100
Initial wound area
Analysis of clinical wound closure in each group of wounds
was performed through digital processing on days 0, 3, 5, 7,
and 11.
Processing and preparation of skin tissues
On days 3 (n=4), 7 (n=4), and 11 (n=8) after wounding,
guinea pigs were euthanized using ketamine and the four
wounded tissues from each guinea pig were excised. Then the
tissues were cut into halves; one half was placed in formalin
(10% formaldehyde in phosphate-buffered saline) for hema-
toxylin-eosin and Masson-trichrome staining, and the second
half was quickly kept as a frozen state (-80℃) for immuno-
histochemistry.
Histology
The specimens for histological examination were collected
from each group by the full-thickness excision. Intensity of
the collagen fibers and the fibroblast proliferation were exam-
ined under microscope in hematoxylin-eosin and Masson-tri-
chrome staining. The staining intensity of the collagen fibers
was graded under ×200 magnification as follows: -, com-
pletely negative staining intensity; ±, lower staining inten-
sity; +, moderate staining intensity; ++, slightly higher
staining intensity; +++, considerably higher staining inten-
sity. The number of fibroblasts was counted in the 5 random-
ized fields per specimen under ×400 magnification. Three
dermatologists, who were ‘‘blinded’’ to which groups the spec-
imens were in, independently analyzed all the specimens and
then the mean numbers and standard deviations of the fibrob-
lasts in all groups of wound were calculated, respectively.
Immunohistochemical staining
All the cryostat sections (5 μ m) of the healing wounds of
guinea pigs were placed on coated micro slides (Muto-glass,
Tokyo, Japan) for immunohistochemical staining procedures.
The samples for immunohistochemistry were washed sever-
al times with 0.1 M phosphate buffered saline (PBS) and then370 H.S. Kim, S.U. Noh, Y.W. Han, et al.
reacted for 15 min with 0.3% H2O2 solution diluted with
PBS to inactivate the endogenous peroxidase in the tissues.
After washing three times for 10 min with PBS, the nonspe-
cific antigen-antibody reactions were inhibited by a 1 hr treat-
ment with 2.5% normal horse serum (R.T.U. Vectastatin
�
Universal ABC Elite kit, Vector Laboratories, Inc., Burlin-
game, CA, U.S.A.). The samples were reacted in 1:100 dilut-
ed solutions of each of the primary antibodies such as rabbit
anti-FGF serum (Santa Cruz Biotechnology Inc., Delaware,
CA, U.S.A.), anti-PDGF serum (Santa Cruz Biotechnology
Inc.), anti-TGF-βserum (Santa Cruz Biotechnology Inc.), and
anti-VEGF serum (Santa Cruz Biotechnology Inc.) at 4℃
for 24 hr. After the primary antibody reaction, each sample
was washed three times for 10 min with PBS, and then they
were reacted at room temperature for 1 hr with treatment of
the secondary antibody solution, biotinylated horse anti-IgG
(R.T.U. Vectastatin
� Universal ABC Elite kit). After wash-
ing three times for 10 min each with PBS, the samples were
reacted at room temperature for 1 hr with avidin-biotin-per-
oxidase complex solution (R.T.U. Vectastatin
�Universal ABC
Elite kit). For the chromogen reactions, the Vector
� Nova-
REDTM substrate kit (Vector Laboratories, Inc., Burlingame,
CA, U.S.A.) was used with reagents 1, 2, and 3 and H2O2 at
room temperature for 3-5 min. After the chromogen reac-
tion, the sample slides were washed three times for 10 min
each with PBS. The washed sample tissues were dried out
on gelatin-coated slides for 2 hr at room temperature. They
are made transparent with xylene treatment and next cov-
ered with polymount. Three ‘‘blinded’’ dermatologists then
independently analyzed the relative intensity of the immuno-
histochemical staining of the slides for FGF, PDGF, TGF-β ,
and VEGF on 5 randomized fields per specimen under ×200
magnification. The intensity was graded as follows: 0, no
positive reaction; +, 1-25% of the cells were positively stained;
++, 26-50% of the cells were positively stained; +++, 51-
75% of the cells were positively stained; ++++, 76-100%
of the cells were positively stained. The mean values of the
scores were analyzed for interpreting the histochemical reac-
tions.
Statistical analysis
All statistical analyses were performed using the ANOVA
followed by Turkey-Kramer’s multiple-comparison test, or
Kruskal-Wallis test of variance with Bonferroni’s correction.
SPSS v10.0 (SPSS Inc., Chicago, IL, U.S.A.) was used for all
calculations. All values were expressed as means and standard
deviations. Differences were considered significant if P<0.05.
RESULTS
The ozonated OLO significantly enhances the acute
cutaneous wound healing
As shown in Fig. 1, there was an enhanced wound closure
in the ozone group of wounds, the left two of the four wounds,
as compared to the oil group as well as the control group. On
Fig. 1. The effects of ozonated olive oil on clinical wound closure. The photomicrographs demonstrate the enhanced wound closure, in
the ozone group, on the left two wounds (a and b) on the back of the guinea pig, as compared to the oil group (c) as well as the control
group (d). (Bar=5 mm).
Day 0 Day 3 Day 5 Day 7 Day 11
a
b
c
d
Difference between the ozone group and the oil group. *P<0.05; 
�
P<0.01. 
Ozone group (n=16) Oil group (n=8) Control (n=8) Post operation day
0 Wound size (mm
2) 31.6±4.1 30.9±3.4 32.0±3.5
Residual wound area (%)  100±0.0 100±0.0 100±0.0
3 Wound size (mm
2) 21.6±3.0 19.3±2.3 18.6±3.0
Residual wound area (%) 68.6±9.7 61.8±6.8 58.0±7.7
5 Wound size ( mm
2) 18.5±3.1 16.3±2.2 15.2±2.6*
Residual wound area (%) 59.3±9.0 53.7±6.8 46.3±6.0*
7 Wound size (mm
2) 9.2±4.1 7.9±3.1 5.0±2.2
�
Residual wound area (%) 29.0±11.0 25.6±10.7 16.4±7.5*
11 Wound size (mm
2) 0.5±0.5 0.2±0.2 0
Residual wound area (%) 1.7±0.9 0.7±0.6 0
Table 1. Comparison of the average wound size and residual wound area on post-operation days 0, 3, 5, 7, and 11Therapeutic Effects of Ozone on Wound Healing 371
day 11, all of the wounds completely re-epithelized irrespec-
tive of treatments. The ozone group showed a significantly
smaller wound size than the oil group on days 5 (P<0.05)
and 7 (P<0.01). The ozone group showed 58%, 46.3%, and
16.4% in residual wound area on days 3, 5 and 7, respective-
ly. On the other hand, the oil group revealed 61.8%, 53.7%
and 25.6% in residual wound area, respectively (Table 1).
Thus, there was a significant difference in the residual wound
area between the ozone group and the oil group on days 5
(P<0.05) and 7 (P<0.01). On repeated-measures of ANOVA,
the ozone group showed a significantly decreased residual
wound area as compared to the oil group, as well as the con-
trol group (P<0.05). 
The ozonated OLO promotes collagen synthesis and
fibroblast proliferation
On the hematoxylin-eosin staining, epithelization, infil-
tration of inflammatory cells and vascular proliferations were
commonly seen on all of the wounds; but there were prolif-
eration of fibroblasts and collagen fibers noted in the ozone
group as well (data not shown). We performed the Masson-
trichrome staining in order to determine whether ozonated
OLO’s ability to accelerate wound closure was associated with
Fig. 2. Masson-trichrome staining of the wound
bed and the edge of the injury site on days 3
and 7. The ozone group revealed the increas-
ed staining intensity of collagen fibers and
the number of fibroblasts at the wound bed
and edge, in comparison to the oil group and
the control group on day 7, but not on day 3
(original magnification ×400, Bar=50 μ m).
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B, wound bed; E, wound edge; -, completely negative staining intensity; ±, lower staining intensity; +, moderate staining intensity; ++, slightly higher
staining intensity; +++, considerably higher staining intensity. *P<0.05.
Ozone group (n=8) Oil group (n=4) Control (n=4)
At post-operation day 3
BEB EBE
Staining intensity of collagen fibers ± + ± + ± +
Number of fibroblasts  30.3±1.3 16.3±1.4 29.7±1.1 17.7±1.7 30.1±1.8 19.3±2.1
At post-operation day 7
BEB EBE
Staining intensity of collagen fibers + ++ ++ ++ +++ +++
Number of fibroblasts 36.9±2.6 16.3±2.1 48.5±2.3 22.7±2.7 62.3±4.4* 35.6±3.1*
Table 2. Comparison of staining intensity of collagen fibers and the number of fibroblasts by the Masson-trichrome staining on days
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collagen synthesis and fibroblast proliferation at the wound
bed and at the edge of the injury site. The staining intensity
of collagen fibers and the number of fibroblasts were evalu-
ated on days 3 and 7. On day 3, the ozone group did not show
a significant difference in the staining intensity of collagen
fibers and the number of fibroblasts as compared to the oil
group. In contrast, on day 7, the ozone group revealed an
increased staining intensity of collagen fibers at the wound
bed and at the edge of the entire dermis in comparison to
the oil and control groups (Fig. 2). On day 7, the numbers
of fibroblasts in the ozone group were 62.3 and 35.6 at the
wound bed and edge, respectively; but, the numbers of fibrob-
lasts in the oil group were 48.5 and 22.7, respectively (Table
2). Thus, there was a significant difference in the staining
intensity of collagen fibers and the number of fibroblasts bet-
ween the ozone group and the oil group on day 7 (P<0.05),
but not on day 3.
The ozone group revealed increased expressions of
PDGF, TGF-β β , and VEGF, but not FGF
In order to determine which growth factors play an impor-
tant role for the accelerating wound closure associated with
the proliferation of fibroblasts and collagen fibers by the ozo-
nated OLO, we evaluated the immunohistochemical stain-
ing intensity of FGF, PDGF, TGF-β , and VEGF on day 7
(Fig. 3). FGF expressions were identified in dermal fibrob-
lasts and collagen fibers, but this was barely detected in the
epidermis of the control group. There were little differences
in the FGF expression between the ozone group and the oil
group (Table 3). PDGF was expressed in dermal inflamma-
tory cells, fibroblasts, epidermal cells and keratinocytes of
hair follicles of the control group. The ozone group revealed
a relatively higher PDGF expression, as compared to the oil
group. There was a relatively distinct difference in the der-
mis between the former and the latter. TGF-βexpressions
were detected in the dermal fibroblasts, epidermal cells and
keratinocytes of the hair follicles of the control group. Like-
wise, the ozone group showed a relatively increased expres-
sion of TGF-β , as compared to the oil group. VEGF expres-
Control
F
G
F
P
D
G
F
T
G
F
-
β
V
E
G
F
Oil group Ozone group
Growth factors
Control
(n=4)
Oil group
(n=4)
Ozone group
(n=8)
FGF Epidermis + + +
Dermis ++ ++ ++
PDGF Epidermis ++ +++ ++++
Dermis ++ ++ ++++
TGF-β Epidermis +++ +++ ++++
Dermis +++ +++ ++++
VEGF Epidermis + ++ ++++
Dermis ++ ++ ++++
Table 3. Comparison of the expression of growth factors on day 7
0, no positive reaction; 1+, the positively staining cells were 1-25%; 2+,
the positively staining cells were 26-50%; 3+, the positively staining cells
were 51-75%; 4+, the positively staining cells were 76-100%.
Fig. 3. Immunohistochemical sta-
ining for FGF, PDGF, TGF-β ‚ and
VEGF on day 7. The ozone group
revealed the relatively increased
expressions of PDGF (B, F, J), TGF-
β (C, G, K), and VEGF (D, H, L), but
not FGF (A, E, I) as compared to
the oil group on day 7 (×100, orig-
inal magnification, inlet; ×400, Bar
=500 μ m).
A E I
B F J
C G K
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sion was identified in dermal fibroblasts, endothelial cells and
collagen fibers, but it was barely detected in the epidermis
of the control group. The ozone group revealed a relatively
increased VEGF expression in both the dermis and the epi-
dermis, as compared to the oil group. These findings demon-
strated that the ozone group revealed relatively higher expres-
sions of PDGF, TGF-β , and VEGF, but not FGF than the oil
group on day 7.
DISCUSSION
Two different ozonized solutions, consisting of sunflower
ozonized oil and ozonated OLO, have been usually used as a
topical form of O3. Because of their antibacterial and anti-
mycotic properties, these ozonated oils have been empirical-
ly used for treating superficial bacterial and fungal infections
(5, 18). Previous studies showed that O3 could affect the ex-
pression of pro-inflammatory cytokines, such as interleukin-1
(IL-1) and tumor necrosis factor-α(TNF-α ), and the adaptive
inflammatory responses including cyclooxygenase-2 (COX-2)
gene activation in keratinocyte via activation of NF-κ B (19,
20). It was also demonstrated that O3 exposure increased
the expression of proliferating cell nuclear antigen (PCNA)
protein and K10, a keratin expressed in well differentiated
suprabasal keratinocytes in skin tissues (20, 21). These find-
ings suggested that O3 could induce the keratinocyte prolif-
eration and differentiation and it could affect skin biology. 
OLO will react with O3, forming ozonide at room temper-
ature in a mildly exothermic reaction. As a sample of OLO
is ozonized, OLO will gain weight as the reaction proceeds.
OLO, high in essential fatty acids, is the only media that will
allow O3 to remain in an active or nascent state for a long
length of time. Two drops of ozonated OLO, about 0.1 mL,
were used in our experiment because it was thought that
about 0.1 mL was sufficient to cover the 6 mm-sized punch
wounds. 
Although there are no reports about the toxicological study
of ozonated OLO, it was reported that sunflower ozonized oil
had no side effects in human-patients (18), except for slight
irritation being noted at the epithelium of mice (22) from
the previous toxicological studies. Because the O3 molecule
can be stabilized as an ozonide between the double bonds of
a monounsaturated fatty acid such as oleic acid (5, 23), ozonat-
ed OLO is an ideal preparation for the topical form of O3 and
it remains stable for 2 yr when stored at 4℃. Furthermore,
ozonated OLO is easy to access as a commercialized form and
to use for applying to cutaneous wound because of its liquid
form. Thus, in this study, we used ozonated OLO as a topi-
cal form of O3 to treat cutaneous wound.
Full-thickness punch wounds used in this study, not includ-
ing panniculectomy, are useful model to evaluate re-epithe-
lization after topical application. Although pigs are often use-
ful models since their cutaneous architecture is most similar
to that of human skin, guinea pigs are cheaper to obtain than
pigs and the care of those is cheaper and easier as well (24). 
Based on the results from the wound closure between the
ozone group and the oil group on days 0, 3, 5, 7, and 11, the
ozone group showed a significantly smaller wound size and
residual wound area than the oil group in the guinea pig model
on days 5 and 7. Thus, these results demonstrated that O3
could enhance acute cutaneous wound healing. Especially,
on day 7, both the wound size and residual wound area of
the ozone group were much more significantly decreased.
This implies that topical exposure of O3 may affect granula-
tion tissue formation of the wound healing process rather
than affecting immediate formation of blood clot and recruit-
ment of inflammatory cells during the inflammation phase. 
On Masson-trichrome staining on day 3, there was not
much difference in the staining intensity of collagen fibers
and fibroblast proliferation between the ozone group and the
oil group. However, on day 7, the ozone group revealed about
one and half times increased staining intensity of collagen
fibers and significantly increased fibroblasts at the wound
edge as well as at the wound bed, compared to the oil group.
These findings indicated that O3 may act on acute wound
healing directly or indirectly via collagen synthesis and fibrob-
last proliferation during granulation tissue formation and
the early tissue remodeling phase of wound healing. 
Fibroblasts have been known to play important roles in re-
epithelization, collagen fiber synthesis, extracellular matrix
regeneration, remodeling of wounds, and for the release of
such endogenous growth factors as FGF, PDGF, TGF-β , and
VEGF (1, 25). In this study, increased expressions of PDGF
and TGF-βwere seen in the ozone group on day 7, which is
correlated with increased staining intensity of collagen fibers
and fibroblast proliferation on the same day. There were also
increased expressions of PDGF and TGF-βin the epidermal
keratinocytes and the hair follicular cells adjacent to the injury.
These findings suggest that O3 might induce expressions of
PDGF and TGF-βfrom epidermal keratinocyte as well as
from the dermal fibroblast at the injury site. In the present
study, there was a relatively increased expression of VEGF in
the epidermal keratinocytes of the ozone group on day 7; this
was consistent with the previous study showing that VEGF
was gradually increased from the 1st day to the 7th day of nor-
mal wound healing process (26). On hematoxylin-eosin stain-
ing, the relatively increased vascularity in the ozone group
might be due to the increased expression of VEGF by ozo-
nation. These findings may be associated with the genera-
tion of H2O2 through ozonation, which can directly induce
a VEGF expression and/or indirectly induce it by the induc-
tion of heme oxygenase-1 (27). Because VEGF is main cyto-
kine of vascularization in the late phase of wound healing
(28), further study will be needed to clarify the effect of O3
on the neovascularization of cutaneous wound healing. In
contrast to the increased expressions of PDGF, TGF-β , and
VEGF in the ozone group, there was little difference in the374 H.S. Kim, S.U. Noh, Y.W. Han, et al.
FGF expressions between the ozone group and the oil group
on day 7. One of the possible explanations for this result is
that FGF had already been up-regulated within 24 hr after
wounding (29). 
In conclusion, these results demonstrate that application
of ozonated OLO, the topical form of O3, can accelerate acute
cutaneous wound repair in the guinea pig model by promot-
ing collagen synthesis and fibroblast proliferation at the injury
site and by increasing the expression of growth factors such
as PDGF, TGF-β , and VEGF. Taken together, we can infer
that topical O3 may be regarded as an alternative therapeu-
tic modality to enhance cutaneous wound healing.
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